Board approved audited FY26 results with net profit of ₹70.10 crore, a 28.2% YoY increase from ₹54.65 crore.
Recommended a final dividend of ₹4 (40%) per share, bringing total FY26 dividend to ₹7 (70%) per share.
Preferential allotment of 1,32,827 shares to holding company Dr. Agarwal's Health Care Limited for ₹70 crore completed in September 2025.
Auditors S.R. Batliboi & Associates LLP issued an unmodified opinion on the quarterly and annual financial results.